Clearbridge Health (SGX:1H3) has issued and allotted 1.24 billion new shares under its rights issue, increasing its total share count to 1.86 billion, according to a Wednesday filing on the Singapore Exchange.

The new shares will commence trading on the SGX Catalist board from Dec. 12 and rank equally with existing shares, except for prior distributions.

Odd lots can be traded on the SGX Unit Share Market, though liquidity may be limited.